Xiangyu Medical Co. Ltd. A (688626) — Capital Reinvestment Ratio
Xiangyu Medical Co. Ltd. A (688626) has a Capital Reinvestment Ratio of 3.23x as of September 2025, meaning it reinvests 3% of its operating cash flow (CN¥18.05 Million) in capital expenditures (CN¥58.35 Million). See Xiangyu Medical Co. Ltd. A (688626) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xiangyu Medical Co. Ltd. A Capital Reinvestment Ratio (2017–2024)
This chart tracks Xiangyu Medical Co. Ltd. A's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Xiangyu Medical Co. Ltd. A (2017–2024)
Year-by-year Capital Reinvestment Ratio for Xiangyu Medical Co. Ltd. A from 2017 to 2024. For live market cap and broader valuation context, see Xiangyu Medical Co. Ltd. A (688626) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.46x | CN¥178.59 Million | CN¥438.89 Million | ▲ +16.9% |
| 2023 | 2.10x | CN¥227.91 Million | CN¥479.26 Million | ▲ +93.3% |
| 2022 | 1.09x | CN¥186.70 Million | CN¥203.07 Million | ▲ +34.7% |
| 2021 | 0.81x | CN¥165.88 Million | CN¥133.91 Million | ▲ +25.0% |
| 2020 | 0.65x | CN¥216.40 Million | CN¥139.71 Million | ▲ +377.9% |
| 2019 | 0.14x | CN¥155.94 Million | CN¥21.07 Million | ▲ +42.9% |
| 2018 | 0.09x | CN¥74.20 Million | CN¥7.02 Million | ▼ -62.2% |
| 2017 | 0.25x | CN¥59.31 Million | CN¥14.84 Million | — |